Alta Partners http://www.altapartners.com/ Alta Partners news. en Copyright 2006 Thu, 09 May 2013 00:00:00 +0800 http://www.php.net/ http://blogs.law.harvard.edu/tech/rss <![CDATA[Trevena Inc. and Forest Laboratories Announce Development Collaboration For TRV027]]> http://www.trevenainc.com/news-details.php?id=50

]]> http://www.trevenainc.com/news-details.php?id=50 http://www.trevenainc.com/news-details.php?id=50 Thu, 09 May 2013 00:00:00 +0800 <![CDATA[Portola Announces Its Factor Xa Inhibitor Antidote PRT4445 Produces Rapid, Sustained and Dose-Related Reversal of the Anticoagulant Activity of Eliquis® in Phase II Study]]> http://www.portola.com/pdfs/Portola_antidote_Ph2_results_FINAL.pdf

]]> http://www.portola.com/pdfs/Portola_antidote_Ph2_results_FINAL.pdf http://www.portola.com/pdfs/Portola_antidote_Ph2_results_FINAL.pdf Wed, 08 May 2013 00:00:00 +0800 <![CDATA[Ablynx Starts Pre-Clinical Development of ALX-0962, an Anti-IgE Nanobody, to Treat Severe Allergic Asthma]]> http://hugin.info/137912/R/1699594/560703.pdf

]]> http://hugin.info/137912/R/1699594/560703.pdf http://hugin.info/137912/R/1699594/560703.pdf Tue, 07 May 2013 00:00:00 +0800 <![CDATA[AcelRx Pharmaceuticals Presents Positive Clinical Data for the Sufentanil NanoTab PCA System at ASRA Medical Meeting]]> http://news.acelrx.com/phoenix.zhtml?c=241441&p=irol-acelrxnewsArticle_pf&ID=1814256&highlight=

]]> http://news.acelrx.com/phoenix.zhtml?c=241441&p=irol-acelrxnewsArticle_pf&ID=1814256&highlight= http://news.acelrx.com/phoenix.zhtml?c=241441&p=irol-acelrxnewsArticle_pf&ID=1814256&highlight= Thu, 02 May 2013 00:00:00 +0800 <![CDATA[Esperion Therapeutics Presents Full Results of Phase 2 Clinical Trial Showing Its Novel Oral Therapy ETC-1002 Lowered LDL-C By Up to 43 ]]> http://www.esperion.com/modules/xnews/article.php?storyid=47

]]> http://www.esperion.com/modules/xnews/article.php?storyid=47 http://www.esperion.com/modules/xnews/article.php?storyid=47 Thu, 02 May 2013 00:00:00 +0800